Alectinib in untreated anaplastic lymphoma kinase-positive non-small cell lung cancer

被引：1

作者：

Ruppert, Anne-Marie ^{[1
,2
]}

Mignard, Xavier ^{[1
]}

Wislez, Marie ^{[1
,2
]}

机构：

[1] UPMC Univ Paris 06, Sorbonne Univ, GRC 04, F-75252 Paris, France

[2] Hop Tenon, AP HP, Serv Pneumol, F-75970 Paris, France

来源：

ANNALS OF TRANSLATIONAL MEDICINE | 2017年 / 5卷 / 23期

关键词：

OPEN-LABEL; ALK; CRIZOTINIB; CHEMOTHERAPY; CERITINIB;

D O I：

10.21037/atm.2017.09.05

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 10 条

[1] Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial [J].

Hida, Toyoaki ;

Nokihara, Hiroshi ;

Kondo, Masashi ;

Kim, Young Hak ;

Azuma, Koichi ;

Seto, Takashi ;

Takiguchi, Yuichi ;

Nishio, Makoto ;

Yoshioka, Hiroshige ;

Imamura, Fumio ;

Hotta, Katsuyuki ;

Watanabe, Satoshi ;

Goto, Koichi ;

Satouchi, Miyako ;

Kozuki, Toshiyuki ;

Shukuya, Takehito ;

Nakagawa, Kazuhiko ;

Mitsudomi, Tetsuya ;

Yamamoto, Nobuyuki ;

Asakawa, Takashi ;

Asabe, Ryoichi ;

Tanaka, Tomohiro ;

Tamura, Tomohide .

LANCET, 2017, 390 (10089) :29-39

[2] Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice A French Study [J].

McLeer-Florin, Anne ;

Moro-Sibilot, Denis ;

Melis, Adrien ;

Salameire, Dimitri ;

Lefebvre, Christine ;

Ceccaldi, Francoise ;

de Fraipont, Florence ;

Brambilla, Elisabeth ;

Lantuejoul, Sylvie .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (02) :348-354

[3] Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study [J].

Ou, Sai-Hong Ignatius ;

Ahn, Jin Seok ;

De Petris, Luigi ;

Govindan, Ramaswamy ;

Yang, James Chih-Hsin ;

Hughes, Brett ;

Lena, Herve ;

Moro-Sibilot, Denis ;

Bearz, Alessandra ;

Ramirez, Santiago Viteri ;

Mekhail, Tarek ;

Spira, Alexander ;

Bordogna, Walter ;

Balas, Bogdana ;

Morcos, Peter N. ;

Monnet, Annabelle ;

Zeaiter, Ali ;

Kim, Dong-Wan .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) :661-+

[4] Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer [J].

Peters, Solange ;

Camidge, D. Ross ;

Shaw, Alice T. ;

Gadgeel, Shirish ;

Ahn, Jin S. ;

Kim, Dong-Wan ;

Ou, Sai-Hong I. ;

Perol, Maurice ;

Dziadziuszko, Rafal ;

Rosell, Rafael ;

Zeaiter, Ali ;

Mitry, Emmanuel ;

Golding, Sophie ;

Balas, Bogdana ;

Noe, Johannes ;

Morcos, Peter N. ;

Mok, Tony .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :829-838

[5] Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial [J].

Shaw, Alice T. ;

Kim, Tae Min ;

Crino, Lucio ;

Gridelli, Cesare ;

Kiura, Katsuyuki ;

Liu, Geoffrey ;

Novello, Silvia ;

Bearz, Alessandra ;

Gautschi, Oliver ;

Mok, Tony ;

Nishio, Makoto ;

Scagliotti, Giorgio ;

Spigel, David R. ;

Deudon, Stephanie ;

Zheng, Cheng ;

Pantano, Serafino ;

Urban, Patrick ;

Massacesi, Cristian ;

Viraswami-Appanna, Kalyanee ;

Felip, Enriqueta .

LANCET ONCOLOGY, 2017, 18 (07) :874-886

[6] Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial [J].

Shaw, Alice T. ;

Gandhi, Leena ;

Gadgeel, Shirish ;

Riely, Gregory J. ;

Cetnar, Jeremy ;

West, Howard ;

Camidge, D. Ross ;

Socinski, Mark A. ;

Chiappori, Alberto ;

Mekhail, Tarek ;

Chao, Bo H. ;

Borghaei, Hossein ;

Gold, Kathryn A. ;

Zeaiter, Ali ;

Bordogna, Walter ;

Balas, Bogdana ;

Puig, Oscar ;

Henschel, Volkmar ;

Ou, Sai-Hong Ignatius .

LANCET ONCOLOGY, 2016, 17 (02) :234-242

[7] Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer [J].

Shaw, Alice T. ;

Kim, Dong-Wan ;

Nakagawa, Kazuhiko ;

Seto, Takashi ;

Crino, Lucio ;

Ahn, Myung-Ju ;

De Pas, Tommaso ;

Besse, Benjamin ;

Solomon, Benjamin J. ;

Blackhall, Fiona ;

Wu, Yi-Long ;

Thomas, Michael ;

O'Byrne, Kenneth J. ;

Moro-Sibilot, Denis ;

Camidge, D. Ross ;

Mok, Tony ;

Hirsh, Vera ;

Riely, Gregory J. ;

Iyer, Shrividya ;

Tassell, Vanessa ;

Polli, Anna ;

Wilner, Keith D. ;

Jaenne, Pasi A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (25) :2385-2394

[8]

Shen L, 2014, NEW ENGL J MED, V370, P2537, DOI [10.1056/NEJMoa1311107, 10.1056/NEJMc1404894]

[9] ALK Gene Rearrangements A New Therapeutic Target in a Molecularly Defined Subset of Non-small Cell Lung Cancer [J].

Solomon, Benjamin ;

Varella-Garcia, Marileila ;

Camidge, D. Ross .

JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) :1450-1454

[10] First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study [J].

Soria, Jean-Charles ;

Tan, Daniel S. W. ;

Chiari, Rita ;

Wu, Yi-Long ;

Paz-Ares, Luis ;

Wolf, Juergen ;

Geater, Sarayut L. ;

Orlov, Sergey ;

Cortinovis, Diego ;

Yu, Chong-Jen ;

Hochmair, Maximillian ;

Cortot, Alexis B. ;

Tsai, Chun-Ming ;

Moro-Sibilot, Denis ;

Campelo, Rosario G. ;

McCulloch, Tracey ;

Sen, Paramita ;

Dugan, Margaret ;

Pantano, Serafino ;

Branle, Fabrice ;

Massacesi, Cristian ;

de Castro, Gilberto, Jr. .

LANCET, 2017, 389 (10072) :917-929

← 1 →